Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience

被引：6
|
作者：
Paschos, Paschalis [1 ]
Vlachaki, Efthimia [1 ,2 ]
Pasvanti, Chrisoula [1 ]
Sinakos, Emmanouil [1 ]
Kalpaka, Anastasia [2 ]
Klonizakis, Philippos [1 ]
Perifanis, Vasilios [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Med 2, GR-54249 Thessaloniki, Greece
[2] Ippokratio Hosp, Thalassaemia Unit, Thessaloniki, Greece
来源：
ACTA HAEMATOLOGICA | 2011年 / 126卷 / 04期
关键词：
MANAGEMENT;
D O I：
10.1159/000330516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
    Jose Urquijo, Juan
    Diago, Moises
    Boadas, Jaume
    Planas, Ramon
    Sola, Ricard
    Angel del Olmo, Juan
    Crespo, Javier
    Carlos Erdozain, Jose
    Dolores Anton, Maria
    Arocena, Carlos
    Suarez, Dolores
    Gine, Josep
    Barrera, Josep M.
    Garcia-Samaniego, Javier
    Perez, Ricardo
    Dalmau, Blai
    Montoro, Miguel
    [J]. ANNALS OF HEPATOLOGY, 2013, 12 (01) : 30 - 35
  • [2] Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
    El Naghi, Suzan
    Abdel-Ghaffar, Tawhida Y.
    El-Karaksy, Hanaa
    Abdel-Aty, Elham F.
    El-Raziky, Mona S.
    Allam, Aleef A.
    Helmy, Heba
    El-Araby, Hanaa A.
    Behairy, Behairy E.
    El-Guindi, Mohamed A.
    El-Sebaie, Hatem
    Abdel-Ghaffar, Aisha Y.
    Ehsan, Nermin A.
    El-Hennawy, Ahmed M.
    Sira, Mostafa M.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) : 4681 - 4691
  • [3] Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
    Suzan El Naghi
    Tawhida Y Abdel-Ghaffar
    Hanaa El-Karaksy
    Elham F Abdel-Aty
    Mona S El-Raziky
    Aleef A Allam
    Heba Helmy
    Hanaa A El-Araby
    Behairy E Behairy
    Mohamed A El-Guindi
    Hatem El-Sebaie
    Aisha Y Abdel-Ghaffar
    Nermin A Ehsan
    Ahmed M El-Hennawy
    Mostafa M Sira
    [J]. World Journal of Gastroenterology, 2014, 20 (16) : 4681 - 4691
  • [4] The effectiveness of pegylated interferon and ribavirin combination therapy for chronic hepatitis C in South Korea: a single center experience
    Kim, H.
    Cho, S.
    Han, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 19 - 20
  • [5] EFFICACY AND SAFETY OF PEGYLATED INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS
    Dai, C. -Y.
    Huang, C. -F.
    Yu, M. -L
    Huang, J-F
    Chuang, W-L.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227
  • [6] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    [J]. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [7] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [8] Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia
    Zhang, R. -F.
    Sun, H. -Q.
    Huang, Q.
    Wang, J. -R.
    Zhang, X. -X.
    Liu, X. -N.
    Ma, Q.
    Lu, H. -Z.
    [J]. HAEMOPHILIA, 2010, 16 (03) : 502 - 507
  • [9] The Retreatment of Genotype 4 Chronic Hepatitis C Patients with Pegylated Interferon Alpha-2a and Ribavirin
    Peedikayil, Musthafa
    Al Ashgar, Hamad
    Al Kahtani, Khalid
    Al Sohaibani, Fahad
    Ingvar, Kagevi
    Al Quaiz, Mohammed
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S134 - S134
  • [10] Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection
    Inati, A
    Taher, A
    Ghorra, S
    Koussa, S
    Taha, M
    Aoun, E
    Sharara, AI
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (04) : 644 - 646
12345